Form 4 for ATYR aTYR PHARMA INC
Accepted 2025-02-04 00:00:00 ET · period of report 2025-02-03 · accession 0000950170-25-013884 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-04 | 2025-02-03 | ATYR | Broadfoot Jill Marie | CFO | M - OptEx | — | +3,750 | 33.0K | +13% | — |
| D | 2025-02-04 | 2025-02-04 | ATYR | Broadfoot Jill Marie | CFO | S - Sale+OE | $3.78 | -1,254 | 31.8K | -4% | -$4,740 |
| D | 2025-02-04 | 2025-02-03 | ATYR | Broadfoot Jill Marie | CFO | M - OptEx | $0.00 | -3,750 | 3,750 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-03 | M | A | 3,750 | — | 33,017 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F3) Includes 1,307 shares acquired on November 15, 2024 under the Company's 2015 Employee Purchase Plan. |
| 2 | Common | Common Stock | 2025-02-04 | S | D | 1,254 | $3.78 | 31,763 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2025-02-03 | M | D | 3,750 | $0.00 | 3,750 | D | — · — to — | 3,750 Common Stock | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F5) The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. |